Science Intelligence and InfoPros

Quote: “Blogging is existing, tweeting is connecting”

hbasset — Tue, 16 Apr 2013 19:59:52 +0000

Interesting findings given by several French students, about the power of blogging for young scientists:

“

The transmission of knowledge is a difficult task. You need to multiply the initiatives, and that’s where the blog plays an important role
PhD candidates have little free time, but it is probably the period in their careers when they have the most time to spend “informing the public
blogging is about sharing findings, sharing your work, and creating a digital e-reputation
Blogging also means improving one’s writing skills, editing speed, and scientific analysis, which are all valuable abilities when it comes to writing your thesis
If you write and publish online, make it so that you’ll be read. Post your articles on Facebook, Twitter, or LinkedIn. E-mail your texts to people likely to read them.

Read the full article from:

Science Blogs and Your PhD. A trump card for your scientific career; Available from: http://www.knowtex.com/nav/science-blogs-and-your-phd-a-trump-card-for-your-scientific-career_40002

From Science 2.0 to Pharma 3.0: my interview (Market Intelligence Hub)

hbasset — Fri, 22 Feb 2013 19:43:56 +0000

“We recently caught up with Hervé Basset, specialist librarian in the pharmaceutical industry and owner of the blog “Science Intelligence“, to talk about the inspiration behind his recent book entitled “From Science 2.0 to Pharma 3.0″, published by Chandos Publishing and available on Amazon.“

Read the full article on http://digimind.com/blog/experts/pharma-3-0/

Pharma 3.0: “a monumental shift is happening” (E&Y)

hbasset — Wed, 06 Feb 2013 20:22:20 +0000

“A monumental shift is happening that will impact the future of healthcare, according to an Ernst & Young report, which outlines a new approach to healthcare delivery, leading to the reinvention of commercial models within the pharmaceutical industry. (…)

The report, Progressions – The third place: Healthcare everywhere examines how several forces, including patent cliffs; reduced R&D productivity, pricing pressures, globalization and demographics have made the industry’s long-standing blockbuster business model increasingly outdated. These factors fueled a transition known as the move from Pharma 1.0, a vertically integrated blockbuster model to Pharma 2.0, which is the current model based on a more diversified market portfolios and a broader focus on bottom-line returns, not just top-line growth. The move to Pharma 3.0 won’t be automatic. (…)

“What we’re talking about at a very high level is a move to new healthcare system that is based on value and not volume,” (…)

Signs exist indicating that pharma companies are moving customer centricity (…)

Pharma 3.0 is also significant because it involves the transition from blockbuster drugs to more personalized medicine for smaller populations…

Read the full article:

Burns, Mia. Pharma moving toward more customer-centric models. MedAdNews-Pharmalive, online on February, 5th 2013. Available from:

http://blog.medadnews.com/index.php/2013/02/05/pharma-moving-toward-more-customer-centric-models/

For Pharma 3.0 models, read also:

From Science 2.0 to Pharma 3.0

Available at Chandos: http://www.woodheadpublishing.com/en/book.aspx?bookID=2767&ChandosTitle=1

and on Amazon bookstore: http://www.amazon.com/Science-2-0-Pharma-3-0-Pharmaceutical/dp/1843347091/ref=sr_1_1?s=books&ie=UTF8&qid=1355255814&sr=1-1&keywords=basset+chandos

Information obesity and doctors

hbasset — Wed, 06 Feb 2013 19:55:27 +0000

“one study found that a primary care physician would have to read 341 relevant medical journals and 7,287 monthly articles, equaling more than 627 reading hours per month, just to stay current on all medical literature. But who has time when you’re treating patients?“

http://catalyst.phrma.org/communications-breakdowns-in-the-scientific-community-and-how-to-fix-them/

IFTTT: a wonderful tool to optimize your social presence

hbasset — Wed, 16 Jan 2013 21:38:35 +0000

A review by Information Today Europe:

“IFTTT (also known as “If This Then That”) is a free web service accessible via www.ifttt.com. It allows users with an account to connect over 50 online and messaging services (channels) and automatically feed information and data between those channels. It can be an extremely useful tool for:

Drawing information together from a variety of resources
Sharing information across different networks
Managing information flows
Extending your reach and spreading your message
Backing up and archiving information and files
Creating timely alerts
Doing this all as quickly and easily as possible and in one place

Broadly speaking many of the channels can be broken down the following types (examples given):

Social networks (Twitter, Facebook, LinkedIn)
Bookmarking sites (Delicious, Pinboard)
Image sharing sites (Flickr, Instagram)
Blogging services (Blogger, WordPress)
Video and audio sharing websites (Youtube, Vimeo, Soundcloud)
File storage services (Dropbox, Google Drive)
Document collaboration services (Google Drive, Evernote)
RSS feeds
Email and messaging services (Gmail, SMS)“

Open Access and pseudo-science journals

hbasset — Sun, 06 Jan 2013 11:59:58 +0000

Unfortunately, there is a negative effect of the widely success of the Open Access movement, the emergence of pseudo journals.

Jeffrey Beall maintains a list of these predatory publishers that “ exist only to make money off the author processing charges that are billed to authors upon acceptance of their scientific manuscripts“…

This list is available on:
http://scholarlyoa.com/2012/12/06/bealls-list-of-predatory-publishers-2013/

Open access could prevent rejection of good science

hbasset — Thu, 20 Dec 2012 18:57:19 +0000

Steve Miron, from Wiley, interviewed by Sian Harris:

What role does open access play in research publishing?

It’s clear that open access (OA) is becoming a big trend. However, I see that for the foreseeable future we’ll live in a mixed economy with green OA, gold OA, subscription and approaches that have not been invented yet. It is fun and exciting, with many experiments by publishers. (…)

There has been some great communication between the research community, publishers and policy makers in developing OA policy. It has been done in an enlightened, positive way but I think there’ll be some serious issues that still need to be considered. (…)

How might relationships between researchers and publishers be improved?

We work hard to nurture and maintain a positive relationship with researchers and libraries. No relationship is without some tension or disagreement but we do actively listen to authors, whether what they say is positive or negative.

(…)

We get around 450,000 article submissions a year and publish about a third of them. Some good science is not being published because the materials budgets do not keep pace with R&D spend. I hope as funded OA becomes more part of the scholarly landscape these tensions are addressed and that budgets for publications will be more aligned with the R&D spend.

http://www.researchinformation.info/features/feature.php?feature_id=393

PLOS: ten years and a new look

hbasset — Thu, 20 Dec 2012 18:37:46 +0000

Announcement from the reputed PLOS:

On the eve of our tenth anniversary, we’re pleased to announce that the redesign of all PLOS journals is now live. The three goals of this initiative were to:

Ensure that readers can quickly assess the relevance and importance of an article through a figure browser and highly visible Article-Level Metrics
Improve site navigation to help users discover content more easily
Launch a flexible platform from which to build out future innovations

This refresh offers users more effective ways to access and read content, updates the overall appearance of the sites and harmonizes them with our new PLOS look announced earlier this year.

Read further on:

http://www.plos.org/redesigned-plos-journals-now-launched/

Open innovation, citizen scientists and crowdsourcing

hbasset — Thu, 13 Dec 2012 20:33:51 +0000

Science magazine Scientific American and InnoCentive, Inc., the global leader in open innovation, crowdsourcing, and prize competitions, have announced a partnership for an online hub that seeks to help science enthusiasts solve global scientific problems. The Scientific American Open Innovation Pavilion, scheduled to go live in the spring of 2013, will be jointly hosted on InnoCentive.comand ScientificAmerican.com.
Commercial organisations, government agencies, and non-profits (known as ‘Seekers’) will be able to post ‘Challenges’ on the Scientific American Open Innovation Pavilion. These ‘Challenges’ are well-articulated descriptions of scientific and technical problems that require innovative solutions. The Scientific American Open Innovation Pavilion provides these ‘Seekers’ with unprecedented access to a global pool of problem solvers, including InnoCentive’s existing 275,000-person-strong solver network and Scientific American’s audience of nearly five million monthly visitors to ScientificAmerican.com.

This partnership also marks the growth of InnoCentive’s collaboration with Nature Publishing Group (NPG), Scientific American’s parent organisation. In June 2009, InnoCentive and NPG launched the nature.com Open Innovation Pavilion, which is hosted on InnoCentive.com and nature.com, www.nature.com/openinnovation.

Medical Cases in literature : an open database

hbasset — Wed, 12 Dec 2012 20:42:49 +0000

Open access (OA) publisher BioMed Central has launched a new semantically-enriched search tool, Cases Database, which aims to enhance the discovery, filtering and aggregation of medical case reports from many journals. OA to journal articles published under Creative Commons licences, which permit text mining, enable the literature to be reused as a resource for scientific discovery

More than 11,000 cases from 100 different journals are reportedly available to be freely searched with Cases Database.

Cases Database uses text mining and medical term recognition to filter peer reviewed medical case reports and provide a semantically enriched search experience. The database offers structured search and filtering by condition, symptom, intervention, pathogen, patient demographic and many other data fields, allowing fast identification of relevant case reports to support clinical practice and research. Registered users can save cases, set up e-mail alerts tonew cases matching their search terms, and export their results. Cases Database will be free to access and is expected to be of particular interest to practicing clinicians, researchers, lecturers, drug regulators, patients, students and authors.

Announcement:

http://blogs.biomedcentral.com/bmcblog/2012/12/10/embrace-information-overload-with-cases-database/

http://www.casesdatabase.com/